Zelmina Lubovac

Artificial intelligence (AI) is an important driving force that is rapidly transforming health care and pharmaceutical industries in several ways. The vast amount of biomedical data available today poses unique opportunities to develop a repertoire of AI-based models. Although the results from studies using AI for solving biomedical problems are encouraging, there are numerous scientific challenges associated with AI for life science applications that need to be addressed.

The DMDPipe project aims to develop a pipeline for identifying and analysing disease-causing modules of interacting proteins. The project is expected to contribute to the development of individualised diagnostics and treatment for asthma.